Search Clinical Trials
598,375 trials
ID
Status
Phase
Title
Sponsor
NCT07765160
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese ParticipantsInnovent Biologics (Suzhou) Co. Ltd.Not Yet RecruitingPhase 1
NCT07765160Not Yet Recruiting
Phase 1
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Parti...Innovent Biologics (Suzho...
NCT07766187
Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic CholangiocarcinomaHistoSonics, Inc.Not Yet RecruitingPhase 2
NCT07766187Not Yet Recruiting
Phase 2
Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepat...HistoSonics, Inc.
NCT07765914
Zuberitamab in the First Episode of Paediatric Nephrotic SyndromeChildren's Hospital of Fudan UniversityNot Yet RecruitingPhase 3
NCT07765914Not Yet Recruiting
Phase 3
Zuberitamab in the First Episode of Paediatric Nephrotic SyndromeChildren's Hospital of Fu...
NCT07765043
Electromagnetic Therapy for Cervicogenic DysphagiaUmm Al-Qura UniversityCompletedNot Applicable
NCT07765043Completed
Not Applicable
Electromagnetic Therapy for Cervicogenic DysphagiaUmm Al-Qura University
NCT07766109
Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac SurgeryUniversity Hospital, ToulouseNot Yet RecruitingPhase 4
NCT07766109Not Yet Recruiting
Phase 4
Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac SurgeryUniversity Hospital, Toul...
NCT07765706
A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in Healthy ParticipantsInsmed IncorporatedNot Yet RecruitingPhase 1
NCT07765706Not Yet Recruiting
Phase 1
A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033...Insmed Incorporated
NCT07764900
Transjugular and Transfemoral Embolization for Varicocele.Sohag UniversityRecruitingNot Applicable
NCT07764900Recruiting
Not Applicable
Transjugular and Transfemoral Embolization for Varicocele.Sohag University
NCT07765212
Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS)Eva M.M. StrijbisNot Yet RecruitingPhase 2
NCT07765212Not Yet Recruiting
Phase 2
Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progre...Eva M.M. Strijbis
NCT07764939
Comparative Effects of CIMT and TOT on Hand Function in Post Stroke PatientsRiphah International UniversityActive Not RecruitingNot Applicable
NCT07764939Active Not Recruiting
Not Applicable
Comparative Effects of CIMT and TOT on Hand Function in Post Stroke PatientsRiphah International Univ...
NCT07765121
ViaMente: Feasibility of a Nurse-Led Group Programme for Burnout and Well-Being in Mental Healthcare ProfessionalsCentro Hospitalar Lisboa OcidentalCompletedNot Applicable
NCT07765121Completed
Not Applicable
ViaMente: Feasibility of a Nurse-Led Group Programme for Burnout and Well-Being...Centro Hospitalar Lisboa...
NCT07765589
TU-100 for Accelerating GI Recovery After Major Abdominopelvic Surgery (RC & CAWR)Tsumura USANot Yet RecruitingPhase 2
NCT07765589Not Yet Recruiting
Phase 2
TU-100 for Accelerating GI Recovery After Major Abdominopelvic Surgery (RC & CAW...Tsumura USA
NCT07765797
Development and Validation of a Scale of Propensity for Change in Chronic Disease PreventionUniversity Hospital, ToulouseNot Yet Recruiting
NCT07765797Not Yet Recruiting
—
Development and Validation of a Scale of Propensity for Change in Chronic Diseas...University Hospital, Toul...
NCT07765342
Diastolic Shock Index for Predicting Postspinal HypotensionIstinye UniversityNot Yet Recruiting
NCT07765342Not Yet Recruiting
—
Diastolic Shock Index for Predicting Postspinal HypotensionIstinye University
NCT07765368
BMI Versus Body Fat Percentage - Which is the Better Predictor of Fertility Outcomes in IVF Cycles?Atlantic FertilityEnrolling By Invitation
NCT07765368Enrolling By Invitation
—
BMI Versus Body Fat Percentage - Which is the Better Predictor of Fertility Outc...Atlantic Fertility
NCT07766356
Study of Cognitive-Linguistic Profiles: The Role of Executive Control in AphasiaUniversity Hospital, ToulouseNot Yet RecruitingNot Applicable
NCT07766356Not Yet Recruiting
Not Applicable
Study of Cognitive-Linguistic Profiles: The Role of Executive Control in AphasiaUniversity Hospital, Toul...
NCT07766265
NEST: A Group Intervention for Parents With Complex PTSDSt.Gallen University of Applied SciencesNot Yet RecruitingNot Applicable
NCT07766265Not Yet Recruiting
Not Applicable
NEST: A Group Intervention for Parents With Complex PTSDSt.Gallen University of A...
NCT07765433
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract CancerECOG-ACRIN Cancer Research GroupNot Yet RecruitingPhase 2
NCT07765433Not Yet Recruiting
Phase 2
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared...ECOG-ACRIN Cancer Researc...
NCT07766005
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)Spyre Therapeutics, Inc.Not Yet RecruitingPhase 2
NCT07766005Not Yet Recruiting
Phase 2
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (Th...Spyre Therapeutics, Inc.
NCT07765979
Mediterranean and Low-Histamine Diets for Pediatric Chronic Spontaneous UrticariaSaglik Bilimleri UniversitesiRecruitingNot Applicable
NCT07765979Recruiting
Not Applicable
Mediterranean and Low-Histamine Diets for Pediatric Chronic Spontaneous Urticari...Saglik Bilimleri Universi...
NCT07766512
Five-year Follow-up After Sars-CoV-2 Infection: Prevalence and Evolution of Post-acute Sequalae of COVID-19 (PASC)Fondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07766512Not Yet Recruiting
—
Five-year Follow-up After Sars-CoV-2 Infection: Prevalence and Evolution of Post...Fondazione Policlinico Un...
Result Breakdown
Not yet recruiting14 (70%)
Completed2 (10%)
Recruiting2 (10%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
not_applicable7 (35%)
Phase 25 (25%)
Not Specified4 (20%)
Phase 12 (10%)
Phase 31 (5%)
Phase 41 (5%)